These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
169 related articles for article (PubMed ID: 7542751)
1. Prevalence of anti-hepatitis C virus antibodies and hepatitis C virus viraemia in chronic haemodialysis patients in Libya. Elzouki AN; Bushala M; Tobji RS; Khfaifi M Nephrol Dial Transplant; 1995; 10(4):475-6. PubMed ID: 7542751 [No Abstract] [Full Text] [Related]
2. Prevalence of anti-HCV among haemodialysis patients in Turkey: a multicentre study. Akpolat T; Arik N; Günaydin M; Utaş C; Dilek K; Caglar S; Candan F; Süleymanlar G; Paydaş S; Sen S Nephrol Dial Transplant; 1995; 10(4):479-80. PubMed ID: 7542753 [No Abstract] [Full Text] [Related]
3. Hepatitis C virus antibody and hepatitis C viremia in pediatric dialysis patients in Taiwan. Lin CY; Lin JY; Chen WP Nephron; 1993; 65(4):654. PubMed ID: 7508095 [No Abstract] [Full Text] [Related]
4. Prevalence and role of hepatitis C viraemia in haemodialysis patients in Japan. Hayashi J; Nakashima K; Yoshimura E; Kishihara Y; Ohmiya M; Hirata M; Kashiwagi S J Infect; 1994 May; 28(3):271-7. PubMed ID: 7522260 [TBL] [Abstract][Full Text] [Related]
5. Hepatitis C virus antibodies in patients on hemodialysis. San Miguel G; Crespo J; Echevarria S; D'Francisco A; Gomez Ullate P; Pons Romero F Infect Control Hosp Epidemiol; 1992 May; 13(5):254, 256. PubMed ID: 1375612 [No Abstract] [Full Text] [Related]
6. High prevalence of and risk factors for hepatitis C in haemodialysis patients in Saudi Arabia: a need for new dialysis strategies. Huraib S; al-Rashed R; Aldrees A; Aljefry M; Arif M; al-Faleh FA Nephrol Dial Transplant; 1995; 10(4):470-4. PubMed ID: 7623989 [TBL] [Abstract][Full Text] [Related]
7. Antibodies to hepatitis C virus in blood donors and polytransfused patients of Macau (southeast China). Martins IA; Ling RC; Fai EL; Chai H; do Rosário Vong MA; de Olim GA Vox Sang; 1993; 65(3):245-6. PubMed ID: 7504374 [No Abstract] [Full Text] [Related]
8. Hepatitis C virus infection among chronic dialysis patients in the southeast of France. Provence-Alpes-Côte d'Azur Nephrologists Group. Dussol B; Berthezène P; Brunet P; Berland Y Nephrol Dial Transplant; 1995; 10(4):477-8. PubMed ID: 7542752 [No Abstract] [Full Text] [Related]
9. Anti-HCV antibodies and HCV RNA in Libyan blood donors. Elzouki AN; Beeching NJ; Mutton KJ; Garson JA Vox Sang; 1995; 68(1):65. PubMed ID: 7536992 [No Abstract] [Full Text] [Related]
10. Risk factors for hepatitis C virus sero-positivity among haemodialysis patients receiving care at kidney centre in a tertiary health facility in Maiduguri, Nigeria. Ummate I; Denue BA; Kida IM; Ohioma OJ; Baba DB; Goni W Pan Afr Med J; 2014; 19():305. PubMed ID: 25883732 [TBL] [Abstract][Full Text] [Related]
11. Virological characteristics of hepatitis C virus infection in chronic hemodialysis patients: a cross-sectional study. Fabrizi F; Lunghi G; Guarnori I; Raffaele L; Di Filippo S; Erba G; Pagano A; Locatelli F Clin Nephrol; 1995 Jul; 44(1):49-55. PubMed ID: 7554533 [TBL] [Abstract][Full Text] [Related]
12. Detection of hepatitis C virus in patients with terminal renal disease undergoing dialysis in southern Brazil: prevalence, risk factors, genotypes, and viral load dynamics in hemodialysis patients. Vidales-Braz BM; da Silva NM; Lobato R; Germano FN; da Mota LD; Barros EJ; de Martinez AM Virol J; 2015 Feb; 12():8. PubMed ID: 25644891 [TBL] [Abstract][Full Text] [Related]
13. Prevalence and significance of antibodies to hepatitis C virus among Saudi haemodialysis patients. Ayoola EA; Huraib S; Arif M; al-Faleh FZ; al-Rashed R; Ramia S; al-Mofleh IA; Abu-Aisha H J Med Virol; 1991 Nov; 35(3):155-9. PubMed ID: 1725179 [TBL] [Abstract][Full Text] [Related]
14. Is dialysis environment more important than blood transfusion in transmission of hepatitis C virus during hemodialysis? Kapoor M; el-Reshaid K; al-Mufti S; Sanad NA; Koshy A Vox Sang; 1993; 65(4):331. PubMed ID: 7508661 [No Abstract] [Full Text] [Related]
15. Prevalence of hepatitis C virus antibodies in hemodialysis patients and dialysis staff. Fujiyama S; Kawano S; Sato S; Tanaka M; Goto M; Taura Y; Sato T; Kawahara T; Mizuno K Hepatogastroenterology; 1992 Apr; 39(2):161-5. PubMed ID: 1378811 [TBL] [Abstract][Full Text] [Related]
16. High prevalence of antibodies to hepatitis C virus in three haemodialysis centres in south-western Poland. Hruby Z; Sliwiński J; Molin I; Zalewska M; Knysz B; Czyz W; Steciwko A; Bogucki J; Gładysz A Nephrol Dial Transplant; 1993; 8(8):740-3. PubMed ID: 7692355 [TBL] [Abstract][Full Text] [Related]
17. Seroepidemiology of hepatitis C virus infection in Japan and HCV infection in haemodialysis patients. Yamaguchi K; Kiyokawa H; Machida J; Obayashi A; Nojiri N; Ueda S; Takatsuki K FEMS Microbiol Rev; 1994 Jul; 14(3):253-8. PubMed ID: 7522023 [TBL] [Abstract][Full Text] [Related]
18. Antibodies to hepatitis C virus by second generation test in hemodialyzed patients. Chauveau P; Courouce AM; Lemarec N; Naret C; Poignet JL; Girault A; Ramdame M; Delons S Kidney Int Suppl; 1993 Jun; 41():S149-52. PubMed ID: 7686591 [TBL] [Abstract][Full Text] [Related]
19. Characteristics of chronic hepatitis C virus infection in patients on maintenance haemodialysis. Ozyilkan E; Akpolat T; Arik N; Köseoglu HT; Telatar H Nephrol Dial Transplant; 1994; 9(11):1697-8. PubMed ID: 7532840 [No Abstract] [Full Text] [Related]
20. Antibodies to hepatitis C virus (HCV) in chronic renal failure (CRF) patients on conservative therapy: prevalence, risk factors and relationship to liver disease. Fabrizi F; Marcelli D; Bacchini G; Guarnori I; Erba G; Locatelli F Nephrol Dial Transplant; 1994; 9(7):780-4. PubMed ID: 7526275 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]